Impact of HIV and antiretroviral initiation on skeletal biology
Impact of HIV and antiretroviral initiation on skeletal biology
批准号:
10872816
负责人:
Rosa Maria Affonso Moyses
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-01 至 2024-06-30
关键词:
AIDS preventionAdministrative SupplementAdoptionAgeAgingAnti-Retroviral AgentsAreaAwardBiological AssayBiological MarkersBiologyBiopsyBone DensityBone structureBrazilCaringChronic Kidney FailureClinicalClinical ResearchCohort StudiesCreatinineDataDiseaseDual-Energy X-Ray AbsorptiometryFinite Element AnalysisFractureFrequenciesFumaratesFunctional disorderFutureGeneral PopulationGlomerular Filtration RateGoalsGuidelinesHIVHIV InfectionsImageImpairmentInflammationInstitutionIntegraseInterdisciplinary StudyInternationalKidneyKidney DiseasesKnowledgeLamivudineLongitudinal StudiesMeasuresMolecularNephrologyNephrotic SyndromeOsteoporosisParentsPathway interactionsPatientsPeripheralPersonsPractice ManagementPrevalencePreventionProtease InhibitorProteinsProteinuriaProviderRecommendationRegimenReportingResearchResearch PersonnelResearch TechnicsResolutionRisk FactorsRoleSpectrum AnalysisTenofovirTissuesTrainingTraining ProgramsTubular formationUniversitiesVitamin DVitamin D-Binding ProteinYinacademic preparationantiretroviral therapybonebone cellbone fragilitybone healthbone imagingbone lossbone metabolismbone qualitybone strengthclinical trainingcomorbiditydesignefavirenzhigh riskhuman old age (65+)improvedinhibitorlow and middle-income countriesmechanical propertiesmultidisciplinarynanoindentationolder menparent grantpre-exposure prophylaxisscreeningskeletaltranscriptomicsurinary
中文摘要
摘要
骨质疏松症和骨折是HIV和抗逆转录病毒疗法(ART)的已知并发症,但其机制
由于缺乏组织水平的数据,与艾滋病毒和抗逆转录病毒治疗相关的骨丢失仍不确定。在父母的资助中
(R21TW012367),我们正在进行一项全面的纵向研究,以比较
两种抗逆转录病毒治疗方案(TDF/拉米夫定/法韦伦兹和拉米夫定/多洛替格韦)。我们将评估骨密度和
双能X线骨密度仪(DXA)和高分辨率外周定量CT的强度
(HRpQCT)与有限元分析(目标1),获得成对的髂骨-冠骨活检以评估
使用纳米压痕/拉曼光谱的组织形态计量学和组织水平机械性能(目标2),
并进行骨细胞转录,以探索支持分子途径。随着PWH年龄的增长,肾脏
损伤可能会增加,骨折的频率也会增加。蛋白尿与糖尿病之间的关系
骨质疏松症/骨折已经在艾滋病毒携带者和非HIV携带者中得到承认,尽管机制
尿蛋白丢失和骨脆性的基础尚未确定。特定的抗逆转录病毒药物,如
由于TDF导致近端肾小管功能障碍导致蛋白尿,但其他并存疾病和
传统因素也起到了作用。这本行政副刊提供了一个独特的机会来研究
巴西慢性骨质疏松症患者骨丢失中的蛋白尿。建立在艾滋病毒和骨骼的多学科合作基础上
来自美国和圣保罗S大学的研究人员在父母拨款中设立了这一补充
为老龄化相关研究提供更多的研究机会和能力建设,重点是
肾-骨轴
英文摘要
ABSTRACT
Osteoporosis and fractures are known complications of HIV and antiretroviral therapy (ART) but the mechanisms
of HIV and ART associated bone loss are still uncertain because tissue-level data are lacking. In the parent grant
(R21TW012367), we are performing a comprehensive longitudinal study to compare the skeletal effects of the
two ART regimens (TDF/lamivudine/efavirenz and lamivudine/dolutegravir). We will evaluate bone density and
strength using dual energy Xray absorptiometry (DXA) and High Resolution peripheral Quantitative CT
(HRpQCT) with finite element analysis (Aim 1), obtain paired iliac-crest bone biopsies to evaluate
histomorphometry and tissue-level mechanical properties using nanoindentation/ramen spectroscopy (Aim 2),
and perform bone cell transcriptomics to explore underpinning molecular pathways. As PWH age, renal
impairment is likely to increase as well as frequency of fracture. An association between proteinuria and
osteoporosis/fracture has been recognized in people with and without HIV, although the mechanistic
underpinnings of urinary loss of protein and bone fragility has not been established. Specific antiretrovirals, such
as TDF cause proximal tubular dysfunction resulting in proteinuria but the effect of other co-morbidities and
traditional factors also contribute. This administrative supplement offers a unique opportunity to study the role of
proteinuria in bone loss among PWH in Brazil. Building upon the multidisciplinary collaboration of HIV and bone
researchers from the U.S. and the University of São Paulo established in the parent grant, this supplement will
provide additional opportunities for research and capacity building for aging-related research focusing on the
kidney-bone axis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of HIV and antiretroviral initiation on skeletal biology
-
批准号:10657701
-
项目类别:
-
资助金额:$18.79万
-
财政年份:2022
-
负责人:Rosa Maria Affonso Moyses
-
依托单位:
Impact of HIV and antiretroviral initiation on skeletal biology
-
批准号:10537735
-
项目类别:
-
资助金额:$24.51万
-
财政年份:2022
-
负责人:Rosa Maria Affonso Moyses
-
依托单位:
海外基金